MetaCap

Stoke Therapeutics Statistics

NASDAQ: STOKHealth CareBiotechnology: Pharmaceutical PreparationsUSD

26.81-0.12 (-0.45%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Stoke Therapeutics by the numbers

Stoke Therapeutics has a market capitalization of $1.75 billion based on 65.41M shares outstanding. With trailing EPS of $-3.81, Stoke Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.5% above its 50-day average and 12.6% below its 200-day average.

Average daily trading volume is 1.02M shares, or about $27.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

STOK valuation vs. peer median

STOK compared with the median of 8 peer companies
MetricSTOKPeer medianDifference
Market cap$1.75B$1.78B-2%
Avg. volume1.02M958.02K+6%

Peer median across 8 companies: ETON, TRAX, SDGR, ZYME, KRSA, MRVI, SEPN, VERA.

Valuation

Price / sales (latest FY)
9.51
EPS (TTM)
$-3.81

Price and trading

Previous close
26.93
Open
26.35
Day range
25.94 – 27.78
52-week range
22.05 – 40.22
52-week change
-8.62%
Beta
—
Volume
615.75K

Dividends and events

Annual dividend
None
Next earnings date
Oct 29, 2026

Additional statistics

Market Cap
1.75B
Forward Pe
-6.56
Eps
-3.81
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
40.22
Week52 Low
22.05
Avg Volume
1.02M
Shares Outstanding
65.41M
Ma50
26.16
Ma200
30.67
Earnings Date
Oct 29, 2026
Pct From52w High
-33.34%
Pct From52w Low
21.59%

Related